Biotech · Private company · Houston, TX, US
Stingray Therapeutics
Track this companyFree. Adds Stingray Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- SR-8541APhase 2 · Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)PHASE2 · RECRUITING · started Nov 20, 2024ClinicalTrials.gov NCT06589440 · fetched Nov 12, 2026
NIH awards2
- A Phase 1-2 clinical program for the teatment of Microsatellite Stable Colorectal Cancer with the combination of SR-8541A, Botensilimab, and BalstilimabFiscal year 2026 · $1.5MNIH RePORTER 5R44CA278144-04 · fetched Nov 12, 2026
- A Phase 1-2 clinical program for the teatment of Microsatellite Stable Colorectal Cancer with the combination of SR-8541A, Botensilimab, and BalstilimabFiscal year 2025 · $1.5MNIH RePORTER 2R44CA278144-03 · fetched Nov 12, 2026